Is the Diabetes 'Holy Grail' in Reach?
With empagliflozin, pioglitazone, and liraglutide, we may finally be getting closer to the 'holy grail' of a diabetes drug that also has cardiovascular benefits.
Source: Medscape Diabetes & Endocrinology Podcast - Category: Endocrinology Authors: Medscape Source Type: podcasts
More News: Actos | Cardiology | Cardiovascular | Diabetes | Empagliflozin | Endocrinology | Heart | Jardiance | Podcasts | Victoza